Objective To compare the level of pain reported by women by dose of mifepristone, 200 or
600 mg, and describe the main factors related to the pain level in the 5 days after a medical …

Objectives To evaluate pain and other early adverse events associated with different
regimens of medical abortion up to nine weeks of amenorrhoea. Methods The literature was …

Objectives Few studies have investigated the features associated with pain levels during
abortion. We aimed to investigate the risk factors for experiencing pain during medication …

Background Pain is often cited as one of the worst features of medical abortion. Further,
inadequate pain management may motivate some women to seek unnecessary clinical …

Objective We aimed to characterize the current pain experience of patients completing an
evidence-based mifepristone-misoprostol medication abortion regimen using real-time pain …

Introduction Women experience pain during medical abortion, yet optimal pain management
remains unclear. We studied the pain experience and need of analgesics during early …

Objective To determine if either prophylactic tramadol 50 mg or ibuprofen 400
mg/metoclopramide 10 mg result in lower maximal pain compared to placebo in women≤ …

Previous studies of medical abortion with mifepristone and a prostaglandin have reported
percentages of subjects who experience cramping and/or bleeding relative to prostaglandin …

OBJECTIVES: To compare the experience of pain, need of analgesic interventions,
preference and acceptability in medical abortion up to 49 days of amenorrhea with …

Objectives: Although medical abortion with home use of misoprostol has been shown to be
safe and acceptable, there are few data about the experience of pain during the procedure …